ITCI Intra-Cellular Therapies Inc
6,121
$66.63
$0.98
(1.49%)
| Watchers | 6,121 |
| 52-Wk Low | $45.50 |
| 52-Wk High | $84.89 |
| Market Cap | $6.93B |
| Volume | 153,047.00 |
| 52-Wk High | $84.89 |
| 52-Wk Low | $45.50 |
How Is The Market Feeling About Intra-Cellular Therapies?Benzinga • about 1 month ago
read more...
Share to Feed
Futures Rebound On Strong Earnings Even As Global Market Mood Remains Dismal
S&P futures traded modestly in the green, erasing earlier losses and signaling a recovery after the S&P 500...
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cardiol Therapeutics (CRDL Research Report), Paragon 28...
Analyst Graig Suvannavejh from Mizuho Securities reiterated a Buy rating on Intra-Cellular Therapies (ITCI Research Report) and keeping the price...
Latest Ratings for ITCI
DateFirmActionFromTo Mar 2022SVB LeerinkMaintainsOutperform Feb 2022NeedhamMaintainsBuy Feb 2022Goldman SachsInitiates Coverage OnBuy
View More Analyst Ratings for...
This price move could indicate a change in the trend, and may be a sell signal for investors...
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Intra-Cellular Therapies Inc (ITCI), where a total of 8,817 contracts have traded so far...
This price move could indicate a change in the trend, and may be a sell signal for investors...
This price move could be a signal that ITCI may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...
This is a Bullish indicator signaling ITCI's price could rise from here. Traders may explore going long the stock or buying call options...